“…A high index of suspicion is needed in cases of familial lymphoma, as identifying XLP mutations prior to EBV infection may allow bone marrow transplantation and improve the chances of survival [23]. (1,4,7,10), female control (2,5,8,11), female carrier IV:1 (3,6,9,12). MW: molecular weight markers; 1-3: undigested DNA, GAPDH (positive control); 4-6: undigested DNA, HUMARA; 7-9: MspI-digested, HUMARA; 10-12: HpaII-digested, HUMARA.…”